Improvement of chronic heart failure by dexamethasone is not associated with downregulation of leptin in rats

Acta Pharmacologica Sinica

Volumn 28, Issue 2, 2007, Pages 202-210

  Xia, Qin Gui ^a   Na, Tao ^b   Guo, Yi Min ^a   Bi, Yun Tian ^a   Zhang, Hai Yan ^a   Dai, De Zai ^b  

^a WENZHOU MEDICAL UNIVERSITY   (China)

^b CHINA PHARMACEUTICAL UNIVERSITY   (China)

Author keywords

Chronic heart failure; Dexamethasone; Leptin; Matrix metalloproteinase 2; Matrix metalloproteinase 9; Tissue inhibitor of metalloproteinase 1; Tissue inhibitor of metalloproteinase 2; Tumor necrosis factor alpha

Indexed keywords

DEXAMETHASONE; GELATINASE A; GELATINASE B; LEPTIN; MESSENGER RNA; REACTIVE OXYGEN METABOLITE; TISSUE INHIBITOR OF METALLOPROTEINASE 1; TISSUE INHIBITOR OF METALLOPROTEINASE 2; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; CORONARY ARTERY LIGATION; DOWN REGULATION; GENE EXPRESSION; HEART FAILURE; HEART MUSCLE; HEMODYNAMICS; HISTOLOGY; HYPERLEPTINEMIA; LEFT CORONARY ARTERY; MALE; NONHUMAN; PROTEIN BLOOD LEVEL; RAT; SIGNAL TRANSDUCTION; UPREGULATION;

ANIMALS; CHRONIC DISEASE; DEXAMETHASONE; DOWN-REGULATION; HEART FAILURE; LEPTIN; MALE; MATRIX METALLOPROTEINASES; OXIDATIVE STRESS; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, LEPTIN; RNA, MESSENGER; STAT TRANSCRIPTION FACTORS; TISSUE INHIBITOR OF METALLOPROTEINASES; TUMOR NECROSIS FACTOR-ALPHA; VENTRICULAR REMODELING;

EID: 33846528879     PISSN: 16714083     EISSN: 17457254     Source Type: Journal    
DOI: 10.1111/j.1745-7254.2007.00503.x     Document Type: Article

References (35)

1. Purdham DM, Zou MX, Rajapurohitam V, Karmazyn M. Rat heart is a site of leptin production and action. Am J Physiol Heart Circ Physiol 2004; 287: H2877-84.
2. Wannamethee SG, Tchernova J, Whincup P, Lowe GD, Kelly A, Rumle A, et al. Plasma leptin: associations with metabolic, inflammatory and haemostatic risk factors for cardiovascular disease. Atherosclerosis 2006 May 17. [Epub ahead of print]
3. Piatti PC, Di Mario LD, Monti G, Fragasso F, Sgura A, Caumo A, et al. Association of insulin resistance, hyperleptinemia, and impaired nitric oxide release with in-stent restenosis in patients undergoing coronary stenting. Circulation 2003; 108: 2074-81.
4. Thakur V, Richards R, Reisin E. Obesity, hypertension, and the heart. Am J Med Sci 2001; 321: 242-8.
5. Schulze PC, Kratzsch J, Linke A, Schoene N, Adams V, Gielen S, et al. Elevated serum levels of leptin and soluble leptin receptor in patients with advanced chronic heart failure. Eur J Heart Fail 2003; 5: 33-40.
6. Polyakova V, Hein S, Kostin S, Ziegelhoeffer T, Schaper J. Matrix metalloproteinases and their tissue inhibitors in pressure-overloaded human myocardium during heart failure progression. J Am Coll Cardiol 2004; 44: 1609-18.
7. Seddon M, Looi AYH, Shah M. Oxidative stress and redox signalling in cardiac hypertrophy and heart failure. Heart 2006; 2: [Epub ahead of print].
8. Castellucci MR, De Matteis A, Meisser R, Cancello V, Monsurro D, Islami, et al. Leptin modulates extracellular matrix molecules and metalloproteinases: possible implications for trophoblast invasion. Mol Hum Reprod 2000; 6: 951-8.
9. Li L, Mamputu JC, Wiernsperger N, Renier G. Signaling pathways involved in human vascular smooth muscle cell proliferation and matrix metalloproteinase-2 expression induced by leptin: inhibitory effect of metformin. Diabetes 2005; 54: 2227-34.
10. Xu FP, Chen MS, Wang YZ, Yi Q, Lin SB, Chen AF, et al. Leptin induces hypertrophy via endothelin-1-reactive oxygen species pathway in cultured neonatal rat cardiomyocytes. Circulation 2004 110: 1269-75.
11. Conraads VM, Denollet J, De Clerck LS, Stevens WJ, Bridts CC, Vrints J. Type D personality is associated with increased levels of tumour necrosis factor (TNF)-alpha and TNF-alpha receptors in chronic heart failure. Int J Cardiol 2006; 97: 970-3.
12. Finck BN, Johnson RW. Anti-inflammatory agents inhibit the induction of leptin by tumor necrosis factor-alpha. Am J Physiol Regul Integr Comp Physiol 2002; 282: R1429-35.
13. Ishida-Takahashi R, Uotani S, Abe T, Degawa-Yamauchi M, Fukushima T, Fujita N, et al. Rapid inhibition of leptin signaling by glucocorticoids in vitro and in vivo. J Biol Chem 2004; 279: 19 658-64.
14. Machuca C, Mendoza-Milla C, Cordova E, Mejia S, Covarrubias L, Ventura J, et al. Dexamethasone protection from TNF-alpha-induced cell death in MCF-7 cells requires NF-kappaB and is independent from AKT. BMC Cell Biol 2006; 7: 9.
15. Bruder ED, Jacobson L, Raff H. Plasma leptin and ghrelin in the neonatal rat: interaction of dexamethasone and hypoxia. J Endocrinol 2005; 185: 477-84.
16. Fried SK, Ricci MR, Russell CD, Laferrere B. Regulation of leptin production in humans. J Nutr 2000; 130: S3127-31.
17. Ren JD, Relling P. Interaction between tumor necrosis factor-alpha and leptin-induced inhibition of cardiac contractile function in isolated ventricular myocytes. Cytokine 2005; 32: 213-8.
18. Ren J. Leptin and hyperleptinemia - from friend to foe for cardiovascular function. J Endocrinol 2004; 181: 1-10.
19. Nagaya N, Uematsu M, Kojima M, Ikeda Y, Yoshihara F, Shimizu W, et al. Chronic administration of ghrelin improves left ventricular dysfunction and attenuates development of cardiac cachexia in rats with heart failure. Circulation 2001; 104: 1430-5.
20. Ahmed SH, Clark LL, Pennington WR, Webb CS, Bonnema DD, Leonardi AH, et al. Matrix metalloproteinases/tissue inhibitors of metalloproteinases: relationship between changes in proteolytic determinants of matrix composition and structural, functional, and clinical manifestations of hypertensive heart disease. Circulation 2006; 113: 2089-96.
21. Herpel E, Singer S, Flechtenmacher C, Pritsch M, Sack FU, Hagl S, et al. Extracellular matrix proteins and matrix metalloproteinases differ between various right and left ventricular sites in end-stage cardiomyopathies. Virchows Arch 2005; 446: 369-78.
22. Wagner DR, Delagardelle C, Ernens I, Rouy D, Vaillant M, Beissel J. Matrix metalloproteinase-9 is a marker of heart failure after acute myocardial infarction. J Card Fail 2006; 12: 66-72.
23. -2 gene exacerbates myocardial inflammation and dysfunction in mice with cytokine-induced cardiomyopathy. Am J Physiol Heart Circ Physiol 2005; 289: H1858-64.
24. Chancey AL, Brower GL, Peterson JT, Janicki JS. Effects of matrix metalloproteinase inhibition on ventricular remodeling due to volume overload. Circulation 2002; 105: 1983-8.
25. Minhas KM, Saraiva RM, Schuleri KH, Lehrke S, Zheng M, Saliaris AP, et al. Xanthine oxidoreductase inhibition causes reverse remodeling in rats with dilated cardiomyopathy. Circ Res 2006; 98: 271-9.
26. Moe GW, Marin-Garcia J, Konig A, Goldenthal M, Lu X, Feng Q. In vivo TNF-inhibition ameliorates cardiac mitochondrial dysfunction, oxidative stress, and apoptosis in experimental heart failure. Am J Physiol Heart Circ Physiol 2004; 287: H1813-20.
27. Valen G, Kawakami T, Tahepold P, Dumitrescu A, Lowbeer C, Vaage J. Glucocorticoid pretreatment protects cardiac function and induces cardiac heart shock protein 72. Am J Physiol Heart Circ Physiol 2000; 279: H836-43.
28. Varga E, Nagy N, Lazar J, Czifra G, Bak I, Biro T, et al. Inhibition of ischemia/reperfusion-induced damage by dexamethasone in isolated working rat hearts: the role of cytochrome c release. Life Sci 2004; 75: 2411-23.
29. Ahima RS, Flier JS. Leptin. Annu Rev Physiol 2000; 62: 413-37.
30. Rajapurohitam V, Gan XT, Kirshenbaum M, Karmazyn LA. The obesity-associated peptide leptin induces hypertrophy in neonatal rat ventricular myocytes. Circ Res 2003; 93: 277-9.
31. Tosaki A, Koltai M, Joo F, Adam G, Szerdahelyi P, Lepran I, et al. Actinomycin D suppresses the protective effect of dexamethasone in rats affected by global cerebral ischemia. Stroke 1985; 16: 501-5.
32. Nishii N, Takasu M, Ohba Y, Maeda S, Kitoh K, Ohtsuka Y, et al. Effects of administration of glucocorticoids and feeding status on plasma leptin concentrations in dogs. Am J Vet Res 2006; 67: 266-70.
33. Luo JD, Zhang GS, Chen MS. Leptin and cardiovascular diseases. Drug News Perspect 2005; 18: 427-31.
34. Trujillo ME, Lee MJ, Sullivan S, Feng J, Schneider SH, Greenberg AS, et al. Tumor necrosis factor alpha and glucocorticoid synergistically increase leptin production in human adipose tissue: role for p38 mitogen-activated protein. Clin Endocrinol Metab 2006; 91: 1484-90.
35. Ramsay TG, Richards MP. Hormonal regulation of leptin and leptin receptor expression in porcine subcutaneous adipose tissue. J Anim Sci 2004; 82: 3486-92.